Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Zajecka

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Psychiatry Research|November 22, 2005
The Modified Rush Sexual Inventory: preliminary psychometric findingsDeepa Rao, John Zajecka, Taisa Skubiak
The Journal of Clinical Psychiatry|March 14, 2002
Antidepressant dosing and switching guidelines: focus on nefazodoneJohn Zajecka, Geoffry W McEnany, Kimberly M Lusk
The Journal of Clinical Psychiatry|May 10, 2013
Residual symptoms in major depressive disorder: prevalence, effects, and managementJohn Zajecka, Susan G Kornstein, Pierre Blier
The Lancet. Psychiatry|August 1, 2016
Does folic acid interfere with lamotrigine?David Mischoulon, John Zajecka, Marlene P Freeman, et al.
The Journal of Clinical Psychiatry|November 5, 2025
Efficacy and Tolerability of Esketamine Augmented With Dextromethorphan/Bupropion for Treatment-Resistant Depression: A Case SeriesJoshua C Eloge, Taymaz Joneydian, Kirk McCall, et al.
The Journal of Clinical Psychiatry|February 1, 2023
Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case SeriesMargarete A Wallner, Joshua C Eloge, Ian V Mackey, et al.
Journal of Clinical Psychopharmacology|June 4, 2010
Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trialJohn Zajecka, Alan Schatzberg, Stephen Stahl, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2016
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive DisorderAtul R Mahableshwarkar, John Zajecka, William Jacobson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2015
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive DisorderAtul R Mahableshwarkar, John Zajecka, William Jacobson, et al.
Journal of Psychiatric Research|October 2, 2015
The pro-inflammatory profile of depressed patients is (partly) related to obesityRichard C Shelton, Michael Falola, Li Li, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Psychiatry Research|November 22, 2005
The Modified Rush Sexual Inventory: preliminary psychometric findingsDeepa Rao, John Zajecka, Taisa Skubiak
The Journal of Clinical Psychiatry|March 14, 2002
Antidepressant dosing and switching guidelines: focus on nefazodoneJohn Zajecka, Geoffry W McEnany, Kimberly M Lusk
The Journal of Clinical Psychiatry|May 10, 2013
Residual symptoms in major depressive disorder: prevalence, effects, and managementJohn Zajecka, Susan G Kornstein, Pierre Blier
The Lancet. Psychiatry|August 1, 2016
Does folic acid interfere with lamotrigine?David Mischoulon, John Zajecka, Marlene P Freeman, et al.
The Journal of Clinical Psychiatry|November 5, 2025
Efficacy and Tolerability of Esketamine Augmented With Dextromethorphan/Bupropion for Treatment-Resistant Depression: A Case SeriesJoshua C Eloge, Taymaz Joneydian, Kirk McCall, et al.
The Journal of Clinical Psychiatry|February 1, 2023
Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case SeriesMargarete A Wallner, Joshua C Eloge, Ian V Mackey, et al.
Journal of Clinical Psychopharmacology|June 4, 2010
Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trialJohn Zajecka, Alan Schatzberg, Stephen Stahl, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2016
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive DisorderAtul R Mahableshwarkar, John Zajecka, William Jacobson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2015
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive DisorderAtul R Mahableshwarkar, John Zajecka, William Jacobson, et al.
Journal of Psychiatric Research|October 2, 2015
The pro-inflammatory profile of depressed patients is (partly) related to obesityRichard C Shelton, Michael Falola, Li Li, et al.
Pageof 4